Cardiac and intestinal natriuretic peptides: Insights from genetically modified mice
- 30 June 2005
- Vol. 26 (6) , 1078-1085
- https://doi.org/10.1016/j.peptides.2004.08.031
Abstract
No abstract availableKeywords
This publication has 69 references indexed in Scilit:
- Effects of Pressure Overload on Extracellular Matrix Expression in the Heart of the Atrial Natriuretic Peptide–Null MouseHypertension, 2003
- Disruption of the guanylyl cyclase-C gene leads to a paradoxical phenotype of viable but heat-stable enterotoxin-resistant mice.Journal of Clinical Investigation, 1997
- Natriuretic Peptides Inhibit DNA Synthesis in Cardiac FibroblastsHypertension, 1995
- Vascular Actions of C-Type Natriuretic Peptide in Isolated Porcine Coronary Arteries and Coronary Vascular Smooth Muscle CellsBiochemical and Biophysical Research Communications, 1994
- The circulating bioactive form of human guanylin is a high molecular weight peptide (10.3 kDa)FEBS Letters, 1993
- Hypotension in transgenic mice expressing atrial natriuretic factor fusion genes.Hypertension, 1990
- C-Type natriuretic peptide (CNP): A new member of natriuretic peptide family identified in porcine brainBiochemical and Biophysical Research Communications, 1990
- Isolation and structural analysis of “Urodilatin”, a new peptide of the cardiodilatin-(ANP)-family, extracted from human urineJournal of Molecular Medicine, 1988
- Purification and complete amino acid sequence of α-human atrial natriuretic polypeptide (α-hANP)Biochemical and Biophysical Research Communications, 1984
- A rapid and potent natriuretic response to intravenous injection of atrial myocardial extract in ratsLife Sciences, 1981